Open AccessIn Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
Author(s) -
Renru Han,
Li Ding,
Yang Yang,
Yan Guo,
Daqiang Yin,
Wei Shi,
Peiyuan Zhi,
Demei Zhu,
Qingmei Liu,
Xiaojuan Tan,
Yuanju Zhu,
Jay Zhang,
Li Li,
Fupin Hu
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.01471-21
Subject(s) - tigecycline , broth microdilution , acinetobacter baumannii , microbiology and biotechnology , colistin , imipenem , antimicrobial , biology , antibiotics , antibiotic resistance , bacteria , minimum inhibitory concentration , pseudomonas aeruginosa , genetics
It is reported thatA. baumannii has emerged as an intractable nosocomial pathogen in hospitals especially when it develops resistance to carbapenems and other antibiotics, which limits treatment options and leads to high mortality. In February 2017, the WHO published a list of ESKAPE pathogens designated “priority status” for which new antibiotics are urgently needed.